New eye drops aim to halt blind spot growth in macular degeneration
Disease control
Recruiting now
This study tests whether daily GAL-101 eye drops can slow the growth of geographic atrophy, a type of vision loss in age-related macular degeneration. About 110 adults aged 55 and older with early-stage geographic atrophy will receive either the active eye drops or a placebo. The…
Phase: PHASE2 • Sponsor: Galimedix Therapeutics Inc • Aim: Disease control
Last updated May 17, 2026 12:30 UTC